Clauser K - Search Results

1

Proteomic characterization of human multiple myeloma bone marrow extracellular matrix.

Glavey SV, Naba A, Manier S, Clauser K, Tahri S, Park J, Reagan MR, Moschetta M, Mishima Y, Gambella M, Rocci A, Sacco A, O'Dwyer ME, Asara JM, Palumbo A, Roccaro AM, Hynes RO, Ghobrial IM. Glavey SV, et al. Among authors: clauser k. Leukemia. 2017 Nov;31(11):2426-2434. doi: 10.1038/leu.2017.102. Epub 2017 Mar 27. Leukemia. 2017. PMID: 28344315

2

The matrisome: in silico definition and in vivo characterization by proteomics of normal and tumor extracellular matrices.

Naba A, Clauser KR, Hoersch S, Liu H, Carr SA, Hynes RO. Naba A, et al. Mol Cell Proteomics. 2012 Apr;11(4):M111.014647. doi: 10.1074/mcp.M111.014647. Epub 2011 Dec 9. Mol Cell Proteomics. 2012. PMID: 22159717 Free PMC article.

3

Extracellular matrix signatures of human mammary carcinoma identify novel metastasis promoters.

Naba A, Clauser KR, Lamar JM, Carr SA, Hynes RO. Naba A, et al. Elife. 2014 Mar 11;3:e01308. doi: 10.7554/eLife.01308. Elife. 2014. PMID: 24618895 Free PMC article.

4

Extracellular matrix signatures of human primary metastatic colon cancers and their metastases to liver.

Naba A, Clauser KR, Whittaker CA, Carr SA, Tanabe KK, Hynes RO. Naba A, et al. Among authors: clauser kr. BMC Cancer. 2014 Jul 18;14:518. doi: 10.1186/1471-2407-14-518. BMC Cancer. 2014. PMID: 25037231 Free PMC article.

5

The extracellular matrix: Tools and insights for the "omics" era.

Naba A, Clauser KR, Ding H, Whittaker CA, Carr SA, Hynes RO. Naba A, et al. Matrix Biol. 2016 Jan;49:10-24. doi: 10.1016/j.matbio.2015.06.003. Epub 2015 Jul 8. Matrix Biol. 2016. PMID: 26163349 Free PMC article. Review.

6

Enrichment of Extracellular Matrix Proteins from Tissues and Digestion into Peptides for Mass Spectrometry Analysis.

Naba A, Clauser KR, Hynes RO. Naba A, et al. J Vis Exp. 2015 Jul 23;(101):e53057. doi: 10.3791/53057. J Vis Exp. 2015. PMID: 26273955 Free PMC article.

7

Quantitative proteomic profiling of the extracellular matrix of pancreatic islets during the angiogenic switch and insulinoma progression.

Naba A, Clauser KR, Mani DR, Carr SA, Hynes RO. Naba A, et al. Sci Rep. 2017 Jan 10;7:40495. doi: 10.1038/srep40495. Sci Rep. 2017. PMID: 28071719 Free PMC article.

8

Proteomic analyses of ECM during pancreatic ductal adenocarcinoma progression reveal different contributions by tumor and stromal cells.

Tian C, Clauser KR, Öhlund D, Rickelt S, Huang Y, Gupta M, Mani DR, Carr SA, Tuveson DA, Hynes RO. Tian C, et al. Proc Natl Acad Sci U S A. 2019 Sep 24;116(39):19609-19618. doi: 10.1073/pnas.1908626116. Epub 2019 Sep 4. Proc Natl Acad Sci U S A. 2019. PMID: 31484774 Free PMC article.

9

MatrisomeDB: the ECM-protein knowledge database.

Shao X, Taha IN, Clauser KR, Gao YT, Naba A. Shao X, et al. Nucleic Acids Res. 2020 Jan 8;48(D1):D1136-D1144. doi: 10.1093/nar/gkz849. Nucleic Acids Res. 2020. PMID: 31586405 Free PMC article.

10

Suppression of pancreatic ductal adenocarcinoma growth and metastasis by fibrillar collagens produced selectively by tumor cells.

Tian C, Huang Y, Clauser KR, Rickelt S, Lau AN, Carr SA, Vander Heiden MG, Hynes RO. Tian C, et al. Nat Commun. 2021 Apr 20;12(1):2328. doi: 10.1038/s41467-021-22490-9. Nat Commun. 2021. PMID: 33879793 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

121 results

Search Page